Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Agnès Loeb"'
Autor:
Coralie Courtinard, Sophie Gourgou, William Jacot, Matthieu Carton, Olivier Guérin, Laure Vacher, Aurélie Bertaut, Marie-Cécile Le Deley, David Pérol, Patricia Marino, Christelle Levy, Lionel Uwer, Geneviève Perrocheau, Renaud Schiappa, Florence Bachelot, Damien Parent, Mathias Breton, Thierry Petit, Thomas Filleron, Agnès Loeb, Simone Mathoulin Pélissier, Mathieu Robain, Suzette Delaloge, Carine Bellera
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-13 (2023)
Abstract Background Overall survival (OS) is the gold standard endpoint to assess treatment efficacy in cancer clinical trials. In metastatic breast cancer (mBC), progression-free survival (PFS) is commonly used as an intermediate endpoint. Evidence
Externí odkaz:
https://doaj.org/article/95e587a2739d4813945eb54f7074bcab
Autor:
Matteo Lambertini, Nathalie Olympios, Justine Lequesne, Céline Calbrix, Maxime Fontanilles, Agnès Loeb, Marianne Leheurteur, Isabelle Demeestere, Frédéric Di Fiore, Anne Perdrix, Florian Clatot
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Background: Limited evidence exists on the impact of adding a taxane, using endocrine therapy and carrying a deleterious germline BRCA mutation on ovarian reserve measured by anti-müllerian hormone (AMH) levels of young breast cancer patients receiv
Externí odkaz:
https://doaj.org/article/5032904791f64ff09c26de3e20580bd6
Autor:
Cristian Moldovan, Nicolas Bon-Mardion, Dorel Manu, Vianney Bastit, Jean-Michel Picquenot, Arnaud François, Frédéric Di Fiore, Agnès Loeb, Sébastien Thureau, Vinciane Rainville, Fabrice Jardin, Jean-Paul Marie, Florian Clatot
Publikováno v:
European Archives of Oto-Rhino-Laryngology
European Archives of Oto-Rhino-Laryngology, Springer Verlag, 2019, 276 (2), pp.541-550. ⟨10.1007/s00405-018-5235-6⟩
European Archives of Oto-Rhino-Laryngology, Springer Verlag, 2019, 276 (2), pp.541-550. ⟨10.1007/s00405-018-5235-6⟩
To evaluate the benefit of cetuximab (Cx) addition to platinum-based and 5-fluorouracil chemotherapy (PFU) in unselected recurrent and/or metastatic head and neck cancer patients (R/MHNC) according to KRAS-LCS6 variant status. All patients who receiv
Autor:
Herve Daubert, Marion Lottin, Frédéric Di Fiore, Christian Gray, Thomas Vermeulin, Pierre Czernichow, Mélodie Lucas, Véronique Merle, Hélène Marini, Agnès Loeb, Florian Guisier, Pierre Michel, Rémy De Mil, David Sefrioui
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, 2018, 105 (11), pp.1003-1011. ⟨10.1016/j.bulcan.2018.09.005⟩
Bulletin du Cancer, John Libbey Eurotext, 2018, 105 (11), pp.1003-1011. ⟨10.1016/j.bulcan.2018.09.005⟩
Summary Introduction During the last decade, most studies on totally implanted venous access-associated adverse events (TIVA-AE) were conducted retrospectively and/or were based on a limited sample size. The aim of our survey was two-fold: to estimat
Autor:
Marion David, Marie Degremont, Agnès Loeb, Zena Khaznadar, Marianne Leheurteur, Anne Perdrix, Frédéric Di Fiore, Mathilde Saint-Ghislain, Florian Clatot
Publikováno v:
Reproductive BioMedicine
Reproductive BioMedicine Online, 2017, 35 (4), pp.468-474. ⟨10.1016/j.rbmo.2017.06.005⟩
Reproductive BioMedicine Online, Elsevier, 2017, 35 (4), pp.468-474. ⟨10.1016/j.rbmo.2017.06.005⟩
Reproductive BioMedicine Online, 2017, 35 (4), pp.468-474. ⟨10.1016/j.rbmo.2017.06.005⟩
Reproductive BioMedicine Online, Elsevier, 2017, 35 (4), pp.468-474. ⟨10.1016/j.rbmo.2017.06.005⟩
The impact of chemotherapy on fertility appears to be of essential importance for the youngest cancer survivors. The aim of this study was to assess plasma anti-Mullerian hormone (AMH) evolution, using an automated sensitive AMH immunoassay in women
Autor:
Nathalie Contentin, Hélène Marini, Véronique Merle, Pierre Michel, Luc Thiberville, Jean-François Muir, Frédéric Di Fiore, Agnès Loeb, Emmanuel Huet, Christian Gray, Akpéné Fred, Christian Pfister, Pierre Czernichow, Marion Lottin, Christophe Peillon
Publikováno v:
Supportive Care in Cancer
Supportive Care in Cancer, Springer Verlag (Germany), 2016, 24 (4), pp.1857-1863. ⟨10.1007/s00520-015-2969-1⟩
Supportive Care in Cancer, Springer Verlag (Germany), 2016, 24 (4), pp.1857-1863. ⟨10.1007/s00520-015-2969-1⟩
International audience; PURPOSE:Although considered safer than central venous catheters for administration of cancer chemotherapy, totally implanted venous access (TIVA) is associated with adverse events that may impair prognosis and quality of life
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a48f0c6d2da14517c3b1fc62a6305e7
https://hal-normandie-univ.archives-ouvertes.fr/hal-02379449
https://hal-normandie-univ.archives-ouvertes.fr/hal-02379449
Autor:
Luc Cabel, Matthieu Carton, Barbara Pistilli, Florence Dalenc, Laurence Vanlemnens, Christelle Levy, William Jacot, Michel Debled, Agnes Loeb, Audrey Hennequin, Thibault De la Motte Rouge, Lilian Laborde, Carine Laurent, E. Chamorey, Damien Parent, Thierry Petit, Marie-Ange Mouret-Reynier, Mario Campone, Geneviève Perrocheau, Claire Labreveux, Thomas Bachelot, Mathieu Robain, Florence Lerebours
Publikováno v:
Breast, Vol 56, Iss , Pp 18-25 (2021)
Purpose: Among metastatic breast cancer (MBC) patients, those with a triple-negative breast cancer phenotype (mTNBC) have the worst prognosis, but the benefit of chemotherapy beyond second line on outcome remains uncertain. The purpose of this study
Externí odkaz:
https://doaj.org/article/9d7301cf07844d3c90e440221410f725